Solventum Corp | SOLV - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
Abbott USD 2.39B 27M 2026-03
Align Technology USD 176.6M 81.86M 2025-12
Baxter International USD 121M 12M 2025-09
Becton, Dickinson and Co. USD 393M 117M 2025-12
Cencora USD 955.61M 59.33M 2025-09
Dexcom USD 300M 58.9M 2025-09
Insulet USD 140.2M 17.4M 2025-12
Solventum Corp USD 511M 149M 2025-09
West Pharmaceutical Services USD 161.5M 8.6M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12